Investing
Top Analyst Upgrades & Downgrades (AFL, ALKS, AMLN, GD, GNW, HGSI, IPI, MGM, SNDK, SHAW, VRTX)
Published:
Last Updated:
These are some of this Tuesday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street research firms.
AFLAC Inc. (NYSE: AFL) Cut to Hold at Citigroup.
Alkermes, Inc. (NASDAQ: ALKS) Started as Neutral at Goldman Sachs.
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) Started as Sell at Goldman Sachs.
General Dynamics Corporation (NYSE: GD) Raised to Buy at Argus.
Genworth Financial Inc. (NYSE: GNW) Cut to Underperform at BofA/ML.
Human Genome Sciences, Inc. (NASDAQ: HGSI) Started as Neutral at Goldman Sachs.
Intrepid Potash, Inc. (NYSE: IPI) Raised to Neutral at BofA/ML.
MGM Resorts International (NYSE: MGM) Raised to Buy at BofA/ML.
SanDisk Corporation (NASDAQ: SNDK) Raised to Buy at Sterne Agee.
The Shaw Group Inc. (NYSE: SHAW) Raised to Buy at UBS.
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Started as Buy at Goldman Sachs.
You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
In 20 Years, I Haven’t Seen A Cash Back Card This Good
After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.
A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.
Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
